| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT01953588 Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III… |
Primary endpoint(s) modified |
| 2026-06-03 | NCT06661720 Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab)… |
Trial sites expanded: 410 -> 414 locations |
| 2026-06-03 | NCT06931340 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… |
Trial sites expanded: 186 -> 194 locations |
| 2026-06-03 | NCT06876714 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+… |
Trial sites expanded: 631 -> 656 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-26 | NCT07605364 Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual… | Phase 2/3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05677490 | mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced… | Advanced Esophageal Adenocarcinoma | Recruiting |
| NCT05379153 | Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The… | Anatomic Stage 0 Breast Cancer AJCC v8 | Recruiting |
| NCT06992427 | High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral… | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT05008848 | Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program | Cigarette Smoking-Related Carcinoma | Recruiting |
| NCT05673148 | Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for… | Metastatic Colorectal Adenocarcinoma | Recruiting |
| NCT05976763 | Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for… | Mantle Cell Lymphoma | Recruiting |
| NCT06632327 | Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB… | Resectable Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06661720 | Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab)… | Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT06931340 | Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… | Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT07000084 | Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone)… | Recurrent Non-Muscle Invasive Bladder Carcinoma | Recruiting |
| NCT05812807 | Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… | Anatomic Stage II Breast Cancer AJCC v8 | Recruiting |
| NCT06876714 | ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT07321652 | Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment… | Chronic Lymphocytic Leukemia | Not Yet Recruiting |
| NCT00887146 | Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy… | Brain and Central Nervous System Tumors | Active, Not Recruiting |
| NCT04455750 | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting |
| NCT04340141 | Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable… | Pancreatic Adenosquamous Carcinoma | Active, Not Recruiting |
| NCT03414970 | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients… | Ductal Breast Carcinoma | Active, Not Recruiting |
| NCT04094688 | Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or… | Colorectal Adenocarcinoma | Active, Not Recruiting |
| NCT04637594 | Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy | Locally Advanced Bladder Urothelial Carcinoma | Active, Not Recruiting |
| NCT04939090 | Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT03927027 | Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer… | Breast Cancer Stage I | Active, Not Recruiting |
| NCT04114981 | Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic… | Metastatic Malignant Neoplasm in the Brain | Active, Not Recruiting |
| NCT01905046 | Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia… | Atypical Ductal Breast Hyperplasia | Active, Not Recruiting |
| NCT01953588 | Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III… | Estrogen Receptor-positive Breast Cancer | Active, Not Recruiting |